EcoDrugPlus

Ribosomal Protein S3a

Ensembl ID : ENSLCRG00005011971
Gene Symbol: RPS3A
3 Cross references
360 Possible Orthologues:

Ribosomal Protein S4 X-Linked

Ensembl ID : ENSLCRG00005006930
Gene Symbol: RPS4X
3 Cross references
494 Possible Orthologues:

Ribosomal Protein S5

Ensembl ID : ENSLCRG00005009187
Gene Symbol: RPS5
3 Cross references
264 Possible Orthologues:

Ribosomal Protein S6 Kinase B1

Ensembl ID : ENSLCRG00005011290
Gene Symbol: RPS6KB1
3 Cross references
158 Possible Orthologues:

Ribosomal Protein S7

Ensembl ID : ENSLCRG00005021357
Gene Symbol: RPS7
3 Cross references
349 Possible Orthologues:

Ribosomal Protein S8

Ensembl ID : ENSLCRG00005011011
Gene Symbol: RPS8
3 Cross references
325 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSLCRG00005012908
Gene Symbol: RPS9
3 Cross references
235 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSLCRG00005014977
Gene Symbol: RPSA
3 Cross references
515 Possible Orthologues:

Ribosomal Protein, Large, P0

Ensembl ID : ENSLCRG00005016036
Gene Symbol: RPLP0
3 Cross references
398 Possible Orthologues:

Selectin P

Ensembl ID : ENSLCRG00005013285
Gene Symbol: SELP
1 Cross references
185 Possible Orthologues:

Serpin Peptidase Inhibitor, Clade C (Antithrombin), Member 1

Ensembl ID : ENSLCRG00005007538
Gene Symbol: SERPINC1
3 Cross references
199 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSLCRG00005012715
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
320 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).